Position in BNTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,594,851
New position
Shares Held
119,204
first reported quarter
Ownership
0.047%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Longaeva Partners L.P. holds $177,039,774 across 33 Biotechnology names. BNTX ranks #6 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NRIX |
Nurix Therapeutics, Inc.
|
1,490,202 | $23,098,131 | |
| 2 | FTRE |
Fortrea Holdings Inc.
|
2,046,727 | $19,280,168 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
335,000 | $12,894,150 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
194,589 | $12,200,730 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
24,935 | $11,134,474 | |
| 6 | BNTX |
BioNTech SE
This page
|
119,204 | $10,594,851 | |
| 7 | CTNM |
Contineum Therapeutics, Inc.
|
732,088 | $9,561,069 | |
| 8 | IMTX |
Immatics N.V.
|
780,967 | $7,684,715 |
All Filings in BNTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,594,851 | 119,204 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||